Telefon:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antikoerper-online.de

RAI14 Protein (Retinoic Acid Induced 14) (Transcript Variant 1) (Myc-DYKDDDDK Tag)

RAI14 Spezies: Human Wirt: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
Produktnummer ABIN2714716
$1,019.70
Zzgl. Versandkosten $45.00 und $20.00 Trockeneis
20 μg
Lieferung in 11 Werktagen
  • Target See all RAI14 products
    RAI14 (Retinoic Acid Induced 14 (RAI14))
    Protein-Typ
    Recombinant
    Proteineigenschaft
    Transcript Variant 1
    Spezies
    • 2
    • 1
    Human
    Quelle
    • 2
    • 1
    HEK-293 Cells
    Aufreinigungstag / Konjugat
    Dieses RAI14 Protein ist gelabelt mit Myc-DYKDDDDK Tag.
    Applikation
    Antibody Production (AbP), Standard (STD)
    Produktmerkmale
    • Recombinant human Ankycorbin / RAI14 (transcript variant 1) protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    Reinheit
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
  • Applikationshinweise
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Kommentare

    The tag is located at the C-terminal.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Lagerung
    -80 °C
    Informationen zur Lagerung
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Target
    RAI14 (Retinoic Acid Induced 14 (RAI14))
    Andere Bezeichnung
    Ankycorbin,rai14 (RAI14 Produkte)
    Synonyme
    RAI14, NORPEG, RAI13, 1700008J19Rik, 1700020L11Rik, Ankycorbin, Norpeg, mKIAA1334, retinoic acid induced 14, ankycorbin, RAI14, rai14, LOC100541535, Rai14
    Molekulargewicht
    109.9 kDa
    NCBI Accession
    NP_056392
Sie sind hier:
Kundenservice